257 related articles for article (PubMed ID: 21905498)
1. Percutaneous application of peptidoglycan from Staphylococcus aureus induces infiltration of CCR4+ cells into mouse skin.
Matsui K; Nishikawa A
J Investig Allergol Clin Immunol; 2011; 21(5):354-62. PubMed ID: 21905498
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous application of peptidoglycan from Staphylococcus aureus induces an increase in mast cell numbers in the dermis of mice.
Matsui K; Nishikawa A
Clin Exp Allergy; 2005 Mar; 35(3):382-7. PubMed ID: 15784119
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous application of peptidoglycan from Staphylococcus aureus induces eosinophil infiltration in mouse skin.
Matsui K; Wirotesangthong M; Nishikawa A
Clin Exp Allergy; 2007 Apr; 37(4):615-22. PubMed ID: 17430360
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of Th2 chemokine receptors on T cells from atopic and nonatopic asthmatics in response to Der p 1-pulsed dendritic cells.
Maneechotesuwan K; Wongkajornsilp A; Huabprasert S; Kasetsinsombat K; Suthumansami T
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S62-70. PubMed ID: 20364559
[TBL] [Abstract][Full Text] [Related]
5. Peptidoglycan from Staphylococcus aureus induces IL-4 production from murine spleen cells via an IL-18-dependent mechanism.
Matsui K; Wirotesangthong M; Nishikawa A
Int Arch Allergy Immunol; 2008; 146(3):262-6. PubMed ID: 18270494
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of 5,6-dihydroergosteol-glucoside on atopic dermatitis-like skin lesions via suppression of NF-κB and STAT activation.
Jung M; Lee TH; Oh HJ; Kim H; Son Y; Lee EH; Kim J
J Dermatol Sci; 2015 Sep; 79(3):252-61. PubMed ID: 26100037
[TBL] [Abstract][Full Text] [Related]
7. CCL17 production by mouse langerhans cells stimulated with Staphylococcus aureus cell wall components.
Matsui K; Tofukuji S; Ikeda R
Biol Pharm Bull; 2015; 38(2):317-20. PubMed ID: 25747991
[TBL] [Abstract][Full Text] [Related]
8. Thymus- and activation-regulated chemokine (TARC/CCL17) induces a Th2-dominated inflammatory reaction on intradermal injection in mice.
Vestergaard C; Deleuran M; Gesser B; Larsen CG
Exp Dermatol; 2004 Apr; 13(4):265-71. PubMed ID: 15086343
[TBL] [Abstract][Full Text] [Related]
9. Peptidoglycan-induced T helper 2 immune response in mice involves interleukin-10 secretion from Langerhans cells.
Matsui K; Nishikawa A
Microbiol Immunol; 2013 Feb; 57(2):130-8. PubMed ID: 23163836
[TBL] [Abstract][Full Text] [Related]
10. Expression of chemokine receptor CCR4 and its ligands (CCL17 and CCL22) in murine contact hypersensitivity.
Kusumoto M; Xu B; Shi M; Matsuyama T; Aoyama K; Takeuchi T
J Interferon Cytokine Res; 2007 Nov; 27(11):901-10. PubMed ID: 18052724
[TBL] [Abstract][Full Text] [Related]
11. Peptidoglycan from Staphylococcus aureus induces T(H)2 immune response in mice.
Matsui K; Nishikawa A
J Investig Allergol Clin Immunol; 2012; 22(2):80-6. PubMed ID: 22533229
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous application of peptidoglycan from Staphylococcus aureus induces mast cell development in mouse spleen.
Matsui K; Nishikawa A
Int Arch Allergy Immunol; 2006; 139(4):271-8. PubMed ID: 16491013
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of a histamine 4 receptor antagonist on CCL17 and CCL22 production by monocyte-derived Langerhans cells in patients with atopic dermatitis.
Miyano K; Matsushita S; Tsuchida T; Nakamura K
J Dermatol; 2016 Sep; 43(9):1024-9. PubMed ID: 26892271
[TBL] [Abstract][Full Text] [Related]
14. Blockade of CCR4 in a humanized model of asthma reveals a critical role for DC-derived CCL17 and CCL22 in attracting Th2 cells and inducing airway inflammation.
Perros F; Hoogsteden HC; Coyle AJ; Lambrecht BN; Hammad H
Allergy; 2009 Jul; 64(7):995-1002. PubMed ID: 19630858
[TBL] [Abstract][Full Text] [Related]
15. Lipoteichoic acid from Staphylococcus aureus induces Th2-prone dermatitis in mice sensitized percutaneously with an allergen.
Matsui K; Nishikawa A
Clin Exp Allergy; 2002 May; 32(5):783-8. PubMed ID: 11994106
[TBL] [Abstract][Full Text] [Related]
16. A CCR4 antagonist ameliorates atopic dermatitis-like skin lesions induced by dibutyl phthalate and a hydrogel patch containing ovalbumin.
Matsuo K; Hatanaka S; Kimura Y; Hara Y; Nishiwaki K; Quan YS; Kamiyama F; Oiso N; Kawada A; Kabashima K; Nakayama T
Biomed Pharmacother; 2019 Jan; 109():1437-1444. PubMed ID: 30551395
[TBL] [Abstract][Full Text] [Related]
17. Effect of an antiallergic drug (Olopatadine hydrochloride) on TARC/CCL17 and MDC/CCL22 production by PBMCs from patients with atopic dermatitis.
Furukawa H; Takahashi M; Nakamura K; Kaneko F
J Dermatol Sci; 2004 Dec; 36(3):165-72. PubMed ID: 15541638
[TBL] [Abstract][Full Text] [Related]
18. A Th2 chemokine, TARC, produced by keratinocytes may recruit CLA+CCR4+ lymphocytes into lesional atopic dermatitis skin.
Vestergaard C; Bang K; Gesser B; Yoneyama H; Matsushima K; Larsen CG
J Invest Dermatol; 2000 Oct; 115(4):640-6. PubMed ID: 10998136
[TBL] [Abstract][Full Text] [Related]
19. CCR4 Is Critically Involved in Skin Allergic Inflammation of BALB/c Mice.
Matsuo K; Nagakubo D; Komori Y; Fujisato S; Takeda N; Kitamatsu M; Nishiwaki K; Quan YS; Kamiyama F; Oiso N; Kawada A; Yoshie O; Nakayama T
J Invest Dermatol; 2018 Aug; 138(8):1764-1773. PubMed ID: 29510192
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of Schefflera leucantha extract on production of allergic mediators by Langerhans cells and mast cells.
Matsui K; Wirotesangthong M; Thanakijcharoenpath W; Mungmee C; Nishikawa A
J Investig Allergol Clin Immunol; 2010; 20(6):463-8. PubMed ID: 21243929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
